Changes in Optic Nerve Sheath Diameter in Response to Various Levels of End Tidal Carbon Dioxide Levels
NCT ID: NCT02711774
Last Updated: 2016-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2016-08-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Carbon dioxide being a potent modulator of cerebral vascular tone, alters the ICP by changing the size of cerebral vasculature and thereby, cerebral blood flow (CBF) and this action occurs very rapidly, over e period of few minutes. In a range of PaCO2 20mmHg to 80 mmHg the cerebral blood flow changes in a linear manner. End tidal carbon dioxide concentration(EtCO2) is a surrogate measure of PaCO2 (especially in a haemodyanimically stable patient with healthy lungs ) and is routinely monitored continuously in patients subjected to general anaesthesia. To date there is very little literature on the effects changing EtCO2 on ONSD . This prompted us to conduct this study to find out the effects of different levels of EtCO2 on ONSD.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ONSD was smallest (0.29cm) at EtCO2 30mmHg, and biggest (0.40cm ) at EtCO2 50mmHg while it was intermediate ( 0.34cm) at EtCO2 40 mmHg. These changes in ONSD are direct representation of changes in ICP brought about by changes in CBF due to PaCO2 changes. Based on results of Bland Altman plots, the calculated 95% confidence interval (CI) for the difference of two measures( EtCO2 40mmHg and 30mmHg ) on ONSD was 0. 009 to 0.102 and the calculated CI for the difference of other two measures ( EtCO2 40mmHg and 50mmHg ) on ONSD was 0.152 to 0. 29 and thus were observed to be statistically insignificant.
Recently Kim et al studied ONSD responsiveness to two levels of EtCO2 ,40 and 50mmHg, each measured at 1 and 5min and they observed significant changes in the diameter of ONSD. Thus their results are at variance with our study. Various possibly reasons for differences in findings are Kim et al studied a small number of patients as opposed to a relatively larger sample size in our study. Also they used total intravenous anesthesia combining propofol and remifentanil infusion. This combination is more likely to predispose patients to systemic hypotension which in turn would increase ICP by causing cerebral vasodilation. Other possibility for different results may be that sonographic measurements of ONSD may vary by the observer's skills or even type of ultrasound device.
According to available literature, the upper limit of ONSD used to define ICP more than 20mmHg (raised ICP ) ranges from 0.48 to 0.57 cm. In our study ,the upper limit of ONSD at EtCO2 level 50mmHg was average of 0.40cm which implies that even at EtCO2 50mmHg, intracranial hypertension is a remote possibility in healthy non-neurosurgical patients with normal brain compliance. We kept constant the factors such as position of patients, time of measurement after achieving target EtCO2, measuring ONSD in a single plain ( transverse) and involving same experienced operator,,thereby, avoiding any confounding factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasonography
ONSD will be measured by a 6-13 MHz linear probe of the ultrasound machine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
All India Institute of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Indu Kapoor
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Indu Kapoor
Role: PRINCIPAL_INVESTIGATOR
AIIMS, New Delhi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indu Kapoor
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEC-128/05.02,2016, RP-34/2016
Identifier Type: -
Identifier Source: org_study_id